Antibodies against APRIL as biomarkers for early prognosis of lymphoma pa- tients
Details for Australian Patent Application No. 2006298794 (hide)
International Classifications
Event Publications
17 April 2008 PCT application entered the National Phase
PCT publication WO2007/039489 Priority application(s): WO2007/039489
16 February 2012 Assignment before Grant
Apotech Corporation; University of Geneva The application has been assigned to Enzo Life Sciences, Inc.; University of Geneva Assignments before Grant, Section 113
10 May 2012 Application Accepted
Published as AU-B-2006298794
6 September 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006298787-Thiophene derivatives for the treatment of diabetes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser